ImmunityBio

Beyond's analysis on ImmunityBio

• 2026-08-21 — A securities fraud class action notice highlights potential liability for Capricor Therapeutics and invites affected investors to seek lead plaintiff status

Recent news mentioning ImmunityBio

• 2026-09-23 — ImmunityBio (IBRX) Meeting With Turkish President Fuels Expansion Hopes, Shares Climb 10%
• 2026-08-21 — ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Contact Kessler Topaz Meltzer & Check, LLP

Appears alongside

• IBRX
• LLP

Browse the full archive →